Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 4, 2010The Journal of ImmunologyOpen Access

Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMichael BaslerUniversity of KonstanzMDMaya DajeeNovartis (United States)CMCarlo MollUniversity of Bern

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Basler et al. (2010) studied this question.

synapsesocial.com/papers/69daaa2f84371aa676a3db93https://doi.org/10.4049/jimmunol.0903182
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MHC Class I Expression in Mice Lacking the Proteasome Subunit LMP-71994 · 529 citations
  2. 2IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-62006 · 1,549 citations
  3. 3Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease1993 · 863 citations
  4. 4Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues2008 · 49 citations